WuXi Biologics (Cayman) Inc., an investment holding ... that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing ...

WuXi Biologics (Cayman) Inc., an investment holding ... that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing ...

After delivering strong sales growth last year and with more expansion in mind, CDMO giant Wuxi Biologics is breaking ground ...

Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing project plans, stockpiling ...

Over the past few quarters, we have prioritized disease indications and built a foundation of key CMC and clinical operational activities to set a new benchmark for innovation, scale, and speed.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Wuxi Biologics (Cayman) Inc. + Watchlist Alert WXIBF US Closed Last Updated: Jun 17, 2025 11:05 a.m. EDT Delayed quote $ 3.2500 0.0400 1.25% Previous Close $3.2100 Toggle Chart Options Advanced ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

Under the deal, CRISPR can pick up to two more siRNA targets. 5. WuXi Biologics slims down again, handing off German plant to CDMO Terumo for $167M WuXi Biologics is shedding another facility ...

US intelligence services advised the authors of the BIOSECURE Act that that WuXi AppTec shared confidential data on US customers with the Chinese government, according to a Reuters report.